Skip to main content
Tulane Home Tulane Home

Research Compliance & Research Integrity

Responsible Conduct of Research Fall 2020 Course Info


 

New Faculty Orientation 2020 Video


Research Compliance Office


Guidance for Tulane University Researchers Regarding COVID-19

 

The Tulane University Research Compliance Office (RCO) remains fully operational during the response to the COVID-19 pandemic. We expect this to continue even if the university further suspends on-site operations for purposes of decreasing COVID-19 transmission.

 

As Tulane University makes decisions on how to respond to the COVID-19 pandemic, we want to reassure the university community that our primary concern is the safety of our research participants and the research team members at the university. Our secondary goal is to preserve the scientific integrity of the research and its protocols.

 

Contact Information

 

RCO staff members are working remotely and are available to assist you:

Please contact us if we can assist you. Our policies and procedures are available at https://research.tulane.edu/compliance.

 

Tulane University resources regarding COVID-19

 

The university has issued and continues to update guidance regarding operations during the pandemic. Below are links to current online guidance that may be helpful to you.

 

Additional resources

 

Recommendations from the Centers for Disease Control (CDC): https://www.cdc.gov/coronavirus/2019-nCoV/index.html.

 

Website location of this document: https://research.tulane.edu/compliance

Document last updated: March 20, 2020

 

Research Compliance Logo

On behalf of the Vice President for Research, the University Research Compliance Office assists researchers in order to ensure compliance with regulations, university policies, and accreditation standards that are applicable to research activities, including

  • use of human and animal subjects in research
  • biological safety
  • pre-award grants administration
  • export controls
  • research misconduct
  • responsible conduct of research training
  • responding to Freedom of Information Act (FOIA) requests
  • registering and posting research results in www.ClinicalTrials.gov
  • use of controlled substances.